Literature DB >> 10755730

Endovascular brachytherapy for the prevention of restenosis after angioplasty.

J Kotzerke1, H Hanke, M Höher.   

Abstract

Restenosis is an unsolved clinical and financial limitation of angioplasty. Local irradiation is a new approach for the reduction of restenosis. Several animal studies have demonstrated the effective inhibition of arterial neointimal proliferation by percutaneous or endovascular irradiation. High-dose-rate irradiation from gamma and beta sources can be applied from radioactive wires or seeds and from liquid beta-emitter-filled balloon catheters. Dosimetric calculations have been performed for all relevant radionuclides. An effective dose can be applied within 10 min to the treated arteries. Beta-emitters are characterized by a low tissue penetration, which simplifies radiation protection but complicates the achievement of a homogeneous dose distribution without centering of the irradiation source. Gamma-emitters are characterized by deep tissue penetration and delivery of almost the same dose to all vessel layers; however, considerable care with regard to radiation protection of the environment is required if gamma-emitters are used. The liquid-filled balloon ensures a homogeneous dose delivery due to the self-centring irradiation source but entails the possibility of radioactivity incorporation in the event of balloon rupture. The most attractive radionuclide for this purpose is rhenium-188, which is available from the 188W/188Re generator system. Radiation exposure after accidental incorporation can be limited by chelation with mercaptoacetyltriglycine or by subsequent oral administration of perchlorate. Initial clinical trials have demonstrated the feasibility of the various irradiation techniques and yielded encouraging results. The use of unsealed radioactivity in a balloon catheter involves the nuclear medicine physician in this new field of therapy. This review discusses the concepts, the radiotracers and the results of animal experiments and early clinical trials in the field of endovascular irradiation employed as a possible means to prevent restenosis after angioplasty.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10755730     DOI: 10.1007/s002590050032

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  5 in total

1.  Monte Carlo dose simulation for intracoronary radiation therapy with a rhenium 188 solution-filled balloon with contrast medium.

Authors:  Eun-Hee Kim; Dae Hyuk Moon; Seung-Jun Oh; Chang-Woon Choi; Sang-Moo Lim; Myeong-Ki Hong; Seong-Wook Park
Journal:  J Nucl Cardiol       Date:  2002 May-Jun       Impact factor: 5.952

2.  Intracoronary beta-brachytherapy using a rhenium-188 filled balloon catheter in restenotic lesions of native coronary arteries and venous bypass grafts.

Authors:  Jochen Wöhrle; Bernd Joachim Krause; Thorsten Nusser; Felix M Mottaghy; Thomas Habig; Matthias Kochs; Jörg Kotzerke; Sven N Reske; Vinzenz Hombach; Martin Höher
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-06-22       Impact factor: 9.236

3.  Effect of early external X-ray radiation on arterial restenosis post percutaneous transluminal angioplasty.

Authors:  Jun Cheng; Bujin Liu; Huarong Yu; Qining Fu; Fenghe Li; Yu Zhao
Journal:  Int J Clin Exp Med       Date:  2015-09-15

4.  The effect of early external X-ray radiation on arterial restenosis post percutaneous transluminal angioplasty.

Authors:  Jun Cheng; Bujin Liu; Huarong Yu; Qining Fu; Fenghe Li; Yu Zhao
Journal:  Int J Clin Exp Med       Date:  2015-07-15

5.  Dosimetry in leakage of (188)Re-DTPA during intracoronary balloon brachytherapy.

Authors:  Jin Chul Paeng; Dong Soo Lee; Won Jun Kang; Han-Mo Yang; June-Key Chung; Jae Min Jeong; In-Ho Chae; Myoung-Mook Lee; Myung Chul Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-06-13       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.